Nayar Pharma Private Limited
About Nayar Pharma Private Limited
Data last updated:
Nayar Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 29 May 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U85195RJ1995PTC010113. Its GSTIN is 08AAACN4710F1ZU (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prem Nayar and Atul Nayar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 17 Vinayak Apartments C – 1 Prithvi Raj Road C – Scheme, Jaipur, Rajasthan, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.64 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹3.75 Lakh (net margin 2.3%) and EBITDA of ₹14.31 Lakh (EBITDA margin 8.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹17 Lakh on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB – 17 Vinayak Apartments C – 1 Prithvi Raj Road C – Scheme, Jaipur, Rajasthan, India
- IndustryChemicals and Materials, Chemical Distribution & Retail
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nayar Pharma Private Limited
The main business activity of Nayar Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nayar Pharma Private Limited FY 2025 filings available
Nayar Pharma Private Limited reported revenue of ₹1.64 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nayar Pharma Private Limited
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nayar Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹14.31 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.75 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nayar Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nayar Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nayar Pharma Private Limited
Nayar Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prem Nayar | Director | 29 May 1995 | 31 Years 4 Months | Current |
| Atul Nayar | Director | 29 May 1995 | 31 Years 4 Months | Current |
Peer Comparison of Nayar Pharma Private Limited
Nayar Pharma Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Olefins Coperation Private Limited | ₹1.66 Cr (FY 2024) | •••• | •••• | •••• | Silvassa, Dadra and Nagar Haveli, India | |
| Marklube Specialities Private Limited | ₹1.66 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Karnal, Haryana, India |
| Mak Global Metals Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Bathinda, Punjab, India |
| SRS Lubes Private Limited | ₹1.65 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | New Delhi, Delhi, India |
| SM Life Sciences Private Limited | ₹1.65 Cr (FY 2024) | •••• | •••• | -67.0% | •••• | Hyderabad, Telangana, India |
| Nayar Pharma Private Limited this company | ₹1.64 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Jaipur, Rajasthan, India |
| M V S R Laboratories Private Limited | ₹1.64 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Numaligarh Fuel Technologies Private Limited | ₹1.64 Cr (FY 2024) | •••• | •••• | 185.0% | •••• | Bokakhat, Assam, India |
| Global Plastics and Chemicals India Private Limited | ₹1.63 Cr (FY 2020) | •••• | •••• | -10.0% | •••• | Delhi, India |
| Blue Grain Chemicals Private Limited | ₹1.63 Cr (FY 2024) | •••• | •••• | 34.0% | •••• | Mumbai, Maharashtra, India |
| Planatol Adhesive India Private Limited | ₹1.63 Cr (FY 2017) | •••• | •••• | -26.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Nayar Pharma by revenue in the Chemicals industry (Chemical Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nayar Pharma Private Limited
Nayar Pharma Private Limited is audited by N S RATHORE & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| N S RATHORE & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nayar Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nayar Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jan 2010 | Andhra Bank | ₹17 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Nayar Pharma Private Limited
Nayar Pharma Private Limited has 4 court cases on record: 1 filed by Nayar Pharma, 3 filed against it. 1 case is pending and 3 are disposed. Status as checked between 28 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by State Governments | Pending |
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by State Governments | Disposed |
| High Court of Rajasthan | Court case (SAW) | Filed by the company against an individual | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Nayar Pharma Private Limited
Employment history and EPFO contributions of people linked to Nayar Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nayar Pharma Private Limited
Nayar Pharma Private Limited has 4 board changes on record since 1995: 2 appointments and 2 cessations. The latest: Surender Kumar Nayar ceased to be Director on 28 Jun 2018.
Credit Ratings, Litigation & Regulatory Alerts for Nayar Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nayar Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nayar Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nayar Pharma Private Limited
Nayar Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACN4710F1ZU | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nayar Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nayar Pharma Private Limited
Nayar Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 29 May 1995 (31+ years old) and is registered under CIN U85195RJ1995PTC010113.
Nayar Pharma reported revenue of ₹1.64 Cr for FY 2025 (down 7% YoY).
Nayar Pharma has 2 current directors:
- Prem Nayar - Director
- Atul Nayar - Director
Nayar Pharma reported a net profit of ₹3.75 Lakh (net margin 2.3%) and EBITDA of ₹14.31 Lakh (EBITDA margin 8.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nayar Pharma is -2% over three years and 1% over five years. In the latest year (FY 2025) revenue fell 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nayar Pharma is 08AAACN4710F1ZU, registered in Rajasthan.
The CIN (Corporate Identification Number) of Nayar Pharma is U85195RJ1995PTC010113. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nayar Pharma has 4 court cases on record: 1 filed by the company and 3 filed against it. 1 is pending. Most are in the district courts.
Nayar Pharma was incorporated on 29 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Nayar Pharma by revenue are Olefins Coperation Private Limited, Marklube Specialities Private Limited, Mak Global Metals Private Limited, SRS Lubes Private Limited, SM Life Sciences Private Limited and 5 more, all in the Chemicals industry (Chemical Retail and Distribution).
Surender Kumar Nayar ceased to be Director on 28 Jun 2018. Sonia Nayar ceased to be Director on 28 Aug 2017. Atul Nayar was appointed as Director on 29 May 1995. Nayar Pharma has 4 board changes on record in total.